CSI Market
Sign In | Register

Amneal Pharmaceuticals Inc (AMRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AMRX Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Amneal Pharmaceuticals Inc finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent127.64
Restricted Cash and Cash Equivalents, Current8.64
Cash & Short-term Investments135.00
Accounts receivable0.42
Due from Related Parties, Current RE4.60
Inventories677.95
Other Current Assets969.14
Prepaid Expense And Other Assets Current155.72
Total Current Assets1,947.03
Equipment/Property/Plant Net456.88
Goodwill net593.50
Intangible Assets587.83
Long-term investments3.34
Financial Instruments19.91
Deferred, Prepaid and Other Assets, Noncurrent113.97
Other Assets, Noncurrent53.89
Total Assets3,776.35
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.00
Estimated Litigation Liability, Current18.49
Long-term Debt, Current Maturities LO5.96
Other Liabilities, Current858.74
Total Current Liabilities883.19
Long-term debt2,570.30
Total Long-term Debt2,570.30
Estimated Litigation Liability, Noncurrent LI70.83
Other liabilities, Noncurrent219.01
Operating Lease Right Of Use Asset14.47
Operating Lease Liability Noncurrent13.47
Finance Lease Liability Noncurrent54.88
Total Liabilities3,743.32
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock545.58
Retained Earnings / Accumulated Deficit-415.09
Accumulated Other Comprehensive Income-100.67
Other Equity-100.67
Common Stockholder's Equity-50.93
Non-controlling interests & other83.96
Total Stockholder's Equity33.02
Liabilities & Stockholder's Equity3,776.35
4 historic quarters locked

Sign in to unlock the full Amneal Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Amneal Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001723128-26-000031

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.